Status In progress
Process STA
ID number 1051

Provisional Schedule

Expected publication 25 April 2018

Project Team

Project lead Stephanie Yates

Email enquiries


Companies sponsors Roche Products (tocilizumab)
  Department of Health
  NHS England
  Welsh Government
Patient carer groups Vasculitis UK
  Polymyalgia Rhuematica and Giant Cell Arteritis UK (PMRGCAuk)
Professional groups British Society of Rheumatology
  Royal College of Ophthalmologists
  Royal College of Physicians


Associated public health groups None
Comparator companies None
General commentators All Wales Therapeutics and Toxicology Centre
  British National Formulary
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Welsh Health Specialised Services Committee
Relevant research groups None


Key events during the development of the guidance:

Date Update
23 January 2018 Committee meeting: 2
05 December 2017 - 04 January 2018 Appraisal consultation: 1
09 November 2017 Committee meeting
13 June 2017 Invitation to participate
21 April 2017 In progress, Topic referred
21 April 2017 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance